Skip to main content
logo
Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.613
+0.042 (1.65%)
Aug 10, 2026, 11:46 AM EDT - Market open

Processa Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
77391877
Market Cap Growth
166.10%126.35%-61.96%-51.22%-77.09%-17.69%
Enterprise Value
5.491.872.154.0511.3660.56
Last Close Price
2.612.8822.10167.25550.002450.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.711.331.931.722.363.02
P/TBV Ratio
1.900.681.601.812.454.31

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-00.000.010.020.00
Net Debt / Equity Ratio
-0.67-0.99-0.66-0.91-0.84-0.64
Net Debt / EBITDA Ratio
0.120.400.090.400.241.46
Net Debt / FCF Ratio
0.140.490.100.560.651.88
Quick Ratio
0.852.480.786.446.5116.99
Current Ratio
0.982.541.237.718.4018.87
Return on Equity (ROE)
-347.53%-372.97%-354.51%-178.52%-166.43%-47.20%
Return on Assets (ROA)
-234.67%-253.35%-267.33%-159.05%-156.91%-44.87%
Return on Invested Capital (ROIC)
-3251.58%-4521.82%-2381.97%-1405.68%-536.42%-137.08%
Return on Capital Employed (ROCE)
-356.55%-384.62%-356.93%-180.75%-166.25%-49.04%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-878.52%-969.33%-133.38%-62.83%-5.16%-104.27%
Total Shareholder Return
-878.52%-969.33%-133.38%-62.83%-5.16%-104.27%
SEC Filings: 10-K · 10-Q